Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
How marijuana reclassification could affect North Carolinians
Recommended
Guide: Amusement parks within driving distance of Raleigh
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cellectis S.A. ADR
(NQ:
CLLS
)
2.990
+0.450 (+17.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
299,774
Open
2.700
Bid (Size)
2.810 (2)
Ask (Size)
2.910 (8)
Prev. Close
2.540
Today's Range
2.641 - 3.010
52wk Range
0.9628 - 3.773
Shares Outstanding
45,484,310
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
Today 16:30 EDT
From
Cellectis Inc.
Via
GlobeNewswire
CLLS Stock Earnings: Cellectis Misses EPS, Misses Revenue for Q4 2023
April 29, 2024
CLLS stock results show that Cellectis missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Performance
YTD
-2.61%
-2.61%
1 Month
+17.72%
+17.72%
3 Month
N/A
N/A
6 Month
+13.26%
+13.26%
1 Year
+63.84%
+63.84%
More News
Read More
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
April 29, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
April 22, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Earnings Scheduled For November 6, 2023
November 06, 2023
Via
Benzinga
Earnings Preview: Cellectis
November 03, 2023
Via
Benzinga
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
April 10, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting
April 08, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)
January 16, 2024
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023
December 22, 2023
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis’ Shareholders Meeting to be Held on December 22, 2023
November 17, 2023
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
November 15, 2023
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023
November 06, 2023
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Present Preliminary Results of NATHALI_01 and Updated Results of the BALLI_01 Phases I Trials at the American Society of Hematology (ASH) 65th Annual Meeting
November 02, 2023
From
Cellectis Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 02, 2023
Via
Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
Via
Benzinga
Why Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
November 02, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 02, 2023
Via
InvestorPlace
Cellectis to Report Third Quarter 2023 Financial Results on November 6, 2023
November 01, 2023
From
Cellectis Inc.
Via
GlobeNewswire
Dow Gains Over 100 Points; Fed Leaves Interest Rates Unchanged
November 01, 2023
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 01, 2023
Via
Benzinga
Why Is Cancer Player Cellectis Stock Trading Over 100% Higher Today?
November 01, 2023
Via
Benzinga
Nasdaq Surges Over 100 Points Ahead Of Fed Decision; WeWork Shares Plunge
November 01, 2023
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
US Stocks Mixed; Private Sector Payrolls Increase Less Than Expected
November 01, 2023
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.